Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: Three consecutive phase II trials
- 1 October 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (10), 1171-1174
- https://doi.org/10.1016/0277-5379(85)90010-0
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Estrogen receptor in malignant melanoma: Fact or artefact?European Journal of Cancer and Clinical Oncology, 1983
- Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanomaCancer, 1982
- LONG-TERM COMPLETE REMISSION OF MALIGNANT MELANOMA WITH TAMOXIFENThe Lancet, 1981
- Oestrogen and androgen receptors in melanomaBritish Journal of Cancer, 1980
- TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA1980